|
DDX19B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.33910000047422E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.43669520724643E-11 |
| Normal-vs-Stage2 |
4.350300E-02 |
| Normal-vs-Stage3 |
1.260410E-02 |
| Normal-vs-Stage4 |
2.722800E-01 |
| Stage1-vs-Stage2 |
2.729800E-02 |
| Stage1-vs-Stage3 |
9.962000E-04 |
| Stage1-vs-Stage4 |
5.88539999999416E-05 |
| Stage2-vs-Stage3 |
8.345000E-01 |
| Stage2-vs-Stage4 |
2.822200E-01 |
| Stage3-vs-Stage4 |
2.831200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19069999970911E-07 |
| Normal-vs-AfricanAmerican |
1.082370E-02 |
| Normal-vs-Asian |
1.967790E-01 |
| Caucasian-vs-AfricanAmerican |
8.348600E-01 |
| Caucasian-vs-Asian |
6.632800E-01 |
| AfricanAmerican-vs-Asian |
8.032200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.60149999951199E-07 |
| Normal-vs-Female |
1.09140000004171E-06 |
| Male-vs-Female |
6.456800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.569400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.3957999745482E-09 |
| Normal-vs-Age(61-80Yrs) |
1.978720E-04 |
| Normal-vs-Age(81-100Yrs) |
1.293400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.268980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.112800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.793800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.490490E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.273000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.225400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.239330E-03 |
| Normal-vs-Grade 2 |
4.04959999977805E-08 |
| Normal-vs-Grade 3 |
3.69100000008338E-07 |
| Normal-vs-Grade 4 |
6.492000E-01 |
| Grade 1-vs-Grade 2 |
2.837700E-02 |
| Grade 1-vs-Grade 3 |
4.733600E-02 |
| Grade 1-vs-Grade 4 |
3.164800E-04 |
| Grade 2-vs-Grade 3 |
9.741200E-01 |
| Grade 2-vs-Grade 4 |
3.843800E-04 |
| Grade 3-vs-Grade 4 |
1.355980E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.64990243689545E-12 |
| Normal-vs-ccB subtype |
1.872140E-02 |
| ccA subtype-vs-ccB subtype |
1.65180000000209E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.06199999999157E-05 |
| Normal-vs-N1 |
5.026000E-01 |
| N0-vs-N1 |
3.704800E-01 |
|
|
